Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
Mol Cancer Ther
; 17(3): 603-613, 2018 03.
Article
in En
| MEDLINE
| ID: mdl-29237806
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bone Neoplasms
/
Chordoma
/
T-Box Domain Proteins
/
Xenograft Model Antitumor Assays
/
Fetal Proteins
/
ErbB Receptors
/
Afatinib
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Mol Cancer Ther
Journal subject:
ANTINEOPLASICOS
Year:
2018
Document type:
Article
Affiliation country:
Italy
Country of publication:
United States